Position in VTGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$11,328
-$58,722 QoQ
Shares Held
19,875
-81.3% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GROUP ONE TRADING LLC holds $126,595,183 across 210 Biotechnology names. VTGN ranks #141 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
363,997 | $23,991,042 | |
| 2 | BNTX |
BioNTech SE
|
103,948 | $9,238,898 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
211,817 | $6,892,525 | |
| 4 | AGIO |
Agios Pharmaceuticals, Inc.
|
173,279 | $5,862,028 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
96,001 | $4,566,767 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,357 | $4,178,274 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,399 | $4,171,483 | |
| 8 | ABVX |
Abivax S.A.
|
35,767 | $3,982,655 |
All Filings in VTGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,328 | 19,875 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $70,050 | 106,137 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $102,694 | 28,928 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $14,284 | 7,142 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,922 | 5,569 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $288,294 | 97,727 | Shares | Sole | 2025-05-14 | |
| 2023-09-30 | $394,598 | 75,305 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,473 | 2,392 | Shares | Sole | 2023-08-09 | |
| No filing history on record for this holder in this stock. | ||||||